BWIN trades 3.1% above Wall Street's consensus target of $31.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes BWIN achieves its forward estimates and maintains a stable P/E multiple of 15.9x. This scenario reflects the blended consensus of 10 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, The Baldwin Insurance Group, Inc. (BWIN) has a Wall Street consensus price target of $31.00, based on estimates from 10 covering analysts. With the stock currently trading at $31.98, this represents a potential downside of -3.1%. The company has a market capitalization of $2.21B.
Analyst price targets range from a low of $28.00 to a high of $32.50, representing a 15% spread in expectations. The median target of $32.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, BWIN trades at a trailing P/E of -27.2x and forward P/E of 15.9x. Analysts expect EPS to grow +270.8% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
RYANRyan Specialty Holdings, Inc. | $12.5B | $47.73 | $48.50 | +1.6% | Buy | 21.9x | 19 |
AONAon plc | $71.0B | $334.81 | $361.30 | +7.9% | Buy | 18.2x | 38 |
MRSHMarsh & McLennan Companies, Inc. | $97.7B | $204.82 | $199.40 | +14.6% | Hold | 16.9x | 26 |
WTWWillis Towers Watson Public Limited Company | $31.1B | $328.86 | $358.11 | +8.9% | Buy | 16.6x | 29 |
BROBrown & Brown, Inc. | $24.1B | $72.12 | $72.67 | +0.8% | Hold | 16.3x | 31 |
AJGArthur J. Gallagher & Co. | $72.3B | $281.61 | $284.92 | +1.2% | Buy | 21.5x | 29 |
ERIEErie Indemnity Company | $12.6B | $273.07 | — | — | — | 21.2x | — |
ACGLArch Capital Group Ltd. | $37.5B | $107.28 | $112.50 | +4.9% | Hold | 10.6x | 34 |
HIGThe Hartford Insurance Group, Inc. | $36.7B | $133.99 | $145.40 | +8.5% | Buy | 10.3x | 42 |
TRVThe Travelers Companies, Inc. | $82.4B | $395.20 | $356.18 | -9.9% | Hold | 10.8x | 44 |
Quick answers to the most common questions about buying BWIN stock.
Wall Street's consensus price target for BWIN is $31, -3.1% from its current price of $31.98. The below-market target from 10 analysts suggests limited near-term appreciation.
BWIN has a consensus rating of "Hold" based on 10 Wall Street analysts. The rating breakdown is mixed, with 7 Hold ratings making up the largest segment. The consensus 12-month price target of $31 implies -3.1% downside from current levels.
With a forward P/E of 15.9112x, BWIN trades at a relatively low valuation. The consensus target of $31 implies -3.1% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $32.5 for BWIN, while the most conservative target is $28. The consensus of $31 represents the median expectation. These targets typically reflect 12-month expectations.
BWIN is moderately covered, with 10 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 2 have Buy ratings, 7 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BWIN stock forecast based on 10 Wall Street analysts shows a consensus price target of $31, with estimates ranging from $28 (bear case) to $32.5 (bull case). The median consensus rating is "Hold".
BWIN trades at a forward P/E ratio of 15.9x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on BWIN, with 0 Sell ratings and a price target of $31 (-3.1% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BWIN analyst price targets range from $28 to $32.5, a 15% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $31 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.